Publications by authors named "David Antoniucci"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

611

Total Likes

185

Extended Reach

1,211,902

Social Features

203
T
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Stefanie Schüpke, Franz-Josef Neumann, Maurizio Menichelli, Katharina Mayer, Isabell Bernlochner, Jochen Wöhrle, Gert Richardt, Christoph Liebetrau, Bernhard Witzenbichler, David Antoniucci

N Engl J Med· October 2019

Videos about Article: user user

2 15 201 5 15

View All Article and Social Media Activity
L
Long-Term Mortality Comparison of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated With Culprit-Only or Multivessel Percutaneous Coronary Intervention.
Ruben Vergara, Elisa Vignini, Michele Ciabatti, Angela Migliorini, Renato Valenti, David Antoniucci

Cardiovasc Revasc Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions.
Didier Carrié, Jacques Berland, Stefan Verheye, Karl Eugen Hauptmann, Mathias Vrolix, David Antoniucci

Int J Cardiol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of complete percutaneous revascularization in elderly patients with chronic total occlusion.
Renato Valenti, Angela Migliorini, Maria Grazia De Gregorio, Raffaele Martone, Martina Berteotti, David Antoniucci

Catheter Cardiovasc Interv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers Study.
Alfredo E Rodriguez, Miguel Larribau, Carlos Fernandez-Pereira, Jorge Iravedra, Omar Santaera, David Antoniucci

Clin Med Insights Cardiol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study.
Mariano Valdes-Chavarri, Sasko Kedev, Aleksandar N Neskovic, Cesar Morís de la Tassa, Milan Zivkovic, David Antoniucci

EuroIntervention· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.
Mikkel Schoos, David Power, Usman Baber, Samantha Sartori, Bimmer Claessen, David Antoniucci

Am J Cardiol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.
Luna Cavigli, Carlo Fumagalli, Niccolò Maurizi, Alessandra Rossi, Anna Arretini, David Antoniucci

Int J Cardiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Angiographic Outcomes Comparison of Patients With Left Main Vs Non-Left Main Bifurcation Lesions Treated With Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents.
Ruben Vergara, Renato Valenti, Angela Migliorini, Michele Ciabatti, Maria Grazia De Gregorio, David Antoniucci

J Invasive Cardiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lowering risk score profile during PCI in multiple vessel disease is associated with low adverse events: The ERACI risk score.
Alfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, Hernan Pavlovsky, Juan Del Pozo, David Antoniucci

Cardiovasc Revasc Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty.
Elisa Grifoni, Anna Maria Gori, Betti Giusti, Renato Valenti, Angela Migliorini, David Antoniucci

Eur J Vasc Endovasc Surg· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between CHADS-VASc score, coronary artery disease severity, residual platelet reactivity and long-term clinical outcomes in patients with acute coronary syndrome.
Fernando Scudiero, Chiara Zocchi, Elena De Vito, Giuseppe Tarantini, Rossella Marcucci, David Antoniucci

Int J Cardiol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APpropriateness Assessment in Antiplatelet THerapY (APATHY) registry: Insight from current clinical practice.
Nazario Carrabba, Benedetta Bellandi, Guido Parodi, Emanuele Cecchi, Giorgio Baldereschi, David Antoniucci

Int J Cardiol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial.
Giampaolo Cerisano, Piergiovanni Buonamici, Guido Parodi, Alberto Santini, Guia Moschi, David Antoniucci

Int J Cardiol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
Angela Migliorini, Renato Valenti, Ruben Vergara, Maria Grazia De Gregorio, Eleonora Gabrielli, David Antoniucci

Catheter Cardiovasc Interv· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Primary Patency Rate After Nitinol Self-Expandable Stents Implantation in Long, Totally Occluded Femoropopliteal (TASC II C & D) Lesions.
Mahmoud Farouk Elmahdy, Piergiovanni Buonamici, Maurizio Trapani, Renato Valenti, Angela Migliorini, David Antoniucci

Heart Lung Circ· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical events beyond one year after an acute coronary syndrome: insights from the RECLOSE 2-ACS study.
Guido Parodi, Benedetta Bellandi, Giuseppe Tarantini, Fernando Scudiero, Renato Valenti, David Antoniucci

EuroIntervention· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Risk Score to Predict Long-Term Cardiac Mortality in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated With Primary Percutaneous Intervention.
Ruben Vergara, Renato Valenti, Angela Migliorini, Giampaolo Cerisano, Nazario Carrabba, David Antoniucci

Am J Cardiol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
Ruben Vergara, Renato Valenti, Angela Migliorini, Guido Parodi, Letizia Giurlani, David Antoniucci

J Invasive Cardiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual thrombin potential predicts cardiovascular death in acute coronary syndrome patients undergoing percutaneous coronary intervention.
Monica Attanasio, Rossella Marcucci, Anna Maria Gori, Rita Paniccia, Serafina Valente, David Antoniucci

Thromb Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI.
Benedetta Bellandi, Chiara Zocchi, Ioanna Xanthopoulou, Fernando Scudiero, Renato Valenti, David Antoniucci

Int J Cardiol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding events and maintenance dose of prasugrel: BLESS pilot study.
Nazario Carrabba, Guido Parodi, Rossella Marcucci, Renato Valenti, Anna Maria Gori, David Antoniucci

Open Heart· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Optimal Medical Therapy in the Prognosis of Coronary Artery Disease.
Angela Migliorini, Renato Valenti, David Antoniucci

JACC Cardiovasc Interv· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial.
Jochen Wöhrle, Sinisa Markovic, Wolfgang Rottbauer, Toshiya Muramatsu, Kazushige Kadota, David Antoniucci

EuroIntervention· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity.
Angela Migliorini, Renato Valenti, Guido Parodi, Ruben Vergara, Piergiovanni Buonamici, David Antoniucci

JACC Cardiovasc Interv· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis